Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
Beat Künzli(Beth Israel Deaconess Medical Center), Simon C. Robson(Beth Israel Deaconess Medical Center), Stephan Rath(Technical University of Munich), Aurel Perren(University of Bern), Maria-Isabell Bernlochner(Beth Israel Deaconess Medical Center), Karen M. Dwyer(The Royal Melbourne Hospital), Peter J. Cowan(The University of Melbourne), Robert Rosenberg(Kantonsspital Baselland), Eva Csizmadia(Beth Israel Deaconess Medical Center), Samuel A. Käser(Kantonsspital Baselland), Anthony J.F. d’Apice(St Vincent's Hospital Melbourne), Keiichi Enjyoji(Beth Israel Deaconess Hospital), Helmut Frieß(TUM Klinikum), Christoph A. Maurer(Kantonsspital Baselland)
Cited by 124
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Purinergic Signaling during Inflammation
|New England Journal of Medicine|2012|703